Laser plus drops: a new combo for glaucoma?

NCT ID NCT06819046

Completed Disease control Sponsor: Colorado Ophthalmology Associates PC Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at 70 people with mild to moderate glaucoma or high eye pressure. All received a laser treatment called selective laser trabeculoplasty (SLT). Afterward, half used Rocklatan eye drops and half used artificial tears. The goal was to see if Rocklatan lowered eye pressure more than artificial tears. The study is complete, and results will show if the combination works better.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Rocklatan (netarsudil and latanoprost ophthalmic solution)
What this could lead to: If it works, this could point toward a better way to manage glaucoma by combining laser treatment with medicated eye drops.
What could go wrong: This is a small, single-site study with only 70 participants, so results may not apply to everyone. The improvement might be small or not meaningful in the long run.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLAUCOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

glaucoma ocular hypertension open-angle glaucoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GLAUCOMA

Contacts and locations

Locations

Colorado Ophthalmology Associates PC

Denver, Colorado, 50210, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.